Kenneth Erland Johnson - Insider Trading & Ownership

Entity
Individual
Location
C/O Xeris Pharmaceuticals, Inc., 180 N. Lasalle Street, Suite 1800, Chicago, IL
Summary
The estimated net worth of Kenneth Erland Johnson is at least $918K dollars as of January 31, 2024. Kenneth Erland Johnson is the Senior Vice President, Global Development and Medical Affairs of Xeris Biopharma Holdings, Inc. and owns shares of Xeris Biopharma Holdings, Inc. (XERS) stock worth about $918K.
All Insider Reports
All Insider Reports

Ownership of Kenneth Erland Johnson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
XERS Xeris Biopharma Holdings, Inc. Senior Vice President, Global Development and Medical Affairs $918K Jan 31, 2024
XERS XERIS PHARMACEUTICALS INC Sr. VP Clinical Development, Regulatory, Quality Assurance & Medical Affairs Oct 5, 2021

Insider Transactions Reported by Kenneth Erland Johnson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.